ENABLING STEP CHANGES IN THERAPEUTIC DEVELOPMENT
Human growth factors from human expression models, hypoimmune cell lines to unlock allogeneic pathways, and iPSC reprogramming with the safest downstream clinical profile.
Leverage our technologies to enable your pre-IND activities
As bench scientists first and solution providers second, we have leveraged decades of in-house problem-solving to develop technologies that increase cell-based workflow efficiency and lower experiment costs. Our human recombinant growth factors solicit best-in-class cell bioactivity levels, and our hypoimmune cell lines can accelerate your allogeneic pathway aspirations.